2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or both.
Eric V Rios-DoriaNadeem R Abu-RustumGretchen E GlaserMichaela McGreeAne Gerda ErikssonMelissa PhamPamela SolimanBeyhan AtasevenKaled AlektiarDmitriy ZamarinMario L LeitaoJennifer J MuellerPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Patients with 2009 FIGO stage IIIA endometrial cancer have distinct survival outcomes depending upon adnexal and/or serosal involvement. Progression-free survival was worse for patients with serosal involvement after adjusting for histology, adjuvant treatment, and lymphovascular space invasion.